eConsent Tearing Down Barriers to Oncology Trials

August 9, 2019

Journal for Clinical Studies Article:  With huge leaps in the understanding of cancer resulting in an ever-expanding set of treatment targets, it’s an exciting, yet fiercely competitive, time to be working in oncology. Despite more people surviving the disease than ever before, a staggering 9.6 million people worldwide died from cancer in 2018, making the need for new drugs a global priority. With the search for new treatments stepping up, patient technology and systems that can improve recruitment and retention while contributing to the collection of cleaner, more compliant data are in demand. eConsent, when implemented well, has the potential to help companies rise to the challenge by removing some of the common barriers to clinical development. Co-authored by Bill Byrom and Neetu Pundir, Signant Health.

Previous Guide
Successful Oncology Trials Need Intelligent Supply Management
Successful Oncology Trials Need Intelligent Supply Management

Next Flipbook
Power of Mobile Technology to Optimize Patient Engagement
Power of Mobile Technology to Optimize Patient Engagement

Power of Mobile Technology to Optimize Patient Engagement and Study Success, article, authored by Neetu Pun...